New device aims to sharpen aim of liver cancer radiation
NCT ID NCT07444645
Summary
This study is testing a new catheter system called TriNav for delivering targeted radiation therapy (Y90 radioembolization) to liver tumors. It will compare how well this new system delivers a contrast dye to tumors versus standard catheters, using special CT scans. The main goals are to see if it improves treatment targeting and to check for any safety issues in up to 20 adults with liver tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.